安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Johnson Johnson showcases latest advancements in cancer innovation . . .
†See the NCCN Guidelines for detailed recommendations, including other treatment options ‡ The NCCN Guidelines for NSCLC provide recommendations for certain individual biomarkers that should be tested and recommend testing techniques but do not endorse any specific commercially available biomarker assays or commercial laboratories § The NCCN Content does not constitute medical advice
- Contact us - Johnson Johnson
Get in touch with Johnson Johnson You are now leaving jnj com The site you’re being redirected to is a branded pharmaceutical website
- Proud to call New Jersey home - Johnson Johnson
Johnson Johnson was the first innovative healthcare company to be founded in New Jersey 138 years later we remain an innovation powerhouse, advancing healthcare in the Garden State—and around the globe
- MedTech - Johnson Johnson
At DePuy Synthes, our mission is to keep people moving through innovations in orthopaedic surgery, support and education for providers, and a dedication to improving diversity, inclusivity, and equality throughout the healthcare system
- Johnson Johnson: Changing health for humanity
Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases
- Johnson Johnson Reports Q4 and Full-Year 2024 Results
NEW BRUNSWICK, N J --(BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024 "2024 was a transformative year for Johnson Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson
- Pipeline - Innovative Medicine pipeline | Johnson Johnson - Investors
2025 Key events Major US EU approvals and submissions and phase 2 3 clinical data presentations being planned or achieved for the year Learn more
- J J global websites - Johnson Johnson
See all of Johnson Johnson's global website links
|
|
|